Results 241 to 250 of about 69,085 (277)

Age-Related Multigene Analysis of Colorectal Cancer Using Next-Generation Sequencing. [PDF]

Cancers (Basel)
Kozlowska-Geller M, Nawacki Ł, Wawszczak-Kasza M, Lewitowicz W, Bicki J, Lewitowicz P.   +5 more
europepmc   +1 more source

Regulatory Strengthening as a Pillar of Health System Resilience for Sustainable Immunization. [PDF]

Vaccines (Basel)
Tan-Koi WC, Khoo YK, Lim JC.
europepmc   +1 more source

Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers. [PDF]

Curr Issues Mol Biol
Kaštelan S, Gilevska F, Tomić Z, Živko J, Nikuševa-Martić T.   +4 more
europepmc   +1 more source

Cooperative and antagonistic interactions between sub-clones favour the co-existence of multiple resistance mechanisms in melanoma

Schlegelmilch K, Hollek V, Hooper S, Giangreco G, Bailey S, Macfarlane S, Carminati A, Bowes A, Strohbuecker S, Fu X, Sahai E.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Targeting NRAS in Melanoma

The Cancer Journal, 2012
Cutaneous melanomas have mutations in the NRAS GTPase in 15% of cases. Compared to melanomas with BRAF mutations, or melanomas "wild-type" for BRAF and NRAS, melanomas with NRAS mutations are more likely to be thicker tumors and to have a higher mitotic rate. Preclinical studies indicate that melanoma cells with NRAS mutations are dependent on NRAS for
Fergal C, Kelleher, Grant A, McArthur
openaire   +2 more sources

NRA Economic Planning.

Journal of the American Statistical Association, 1937
Collis Stocking, Charles Fredrick Roos
  +4 more sources

NRAS

2020
Daniela Furlan, Nora Sahnane
openaire   +1 more source

NRA

1992
DANIELE J. CHERNIAK, W.A. LANFORD
openaire   +1 more source

NRAS mutant melanoma: Towards better therapies

Cancer Treatment Reviews, 2021
Ines Kozar, Jochen Utikal, Stephanie Kreis   +2 more
exaly